Showing results (741-750 of 31,429) with videos related to

Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|November 9, 2011
In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organismsCatharine C Bulik, Pamela R Tessier, Rebecca A Keel, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2011
Evaluation of ceftobiprole activity against a variety of gram-negative pathogens, including Escherichia coli, Haemophilus influenzae (β-lactamase positive and β-lactamase negative), and Klebsiella pneumoniae, in a rabbit meningitis modelA Stucki, M Cottagnoud, F Acosta, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2011
Immobilization of antibacterial dihydropyrrol-2-ones on functional polymer supports to prevent bacterial infections in vivoKitty Ka Kit Ho, Nerida Cole, Renxun Chen, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2011
High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospitalEphraim E Back, Elisa J O'Grady, Joshua D Back
Antimicrobial Agents and Chemotherapy|December 7, 2011
E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesisNao-Aki Watanabe, Mamiko Miyazaki, Takaaki Horii, et al.
Antimicrobial Agents and Chemotherapy|October 12, 2011
Evaluation of pharmacokinetic/pharmacodynamic relationships of PD-0162819, a biotin carboxylase inhibitor representing a new class of antibacterial compounds, using in vitro infection modelsAdam Ogden, Michael Kuhn, Michael Dority, et al.
Antimicrobial Agents and Chemotherapy|October 12, 2011
Extended-spectrum-β-lactamase-producing Escherichia coli as a cause of pediatric infections: report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strainJesús Oteo, Emilia Cercenado, Sara Fernández-Romero, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2009
Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensisHao-Chieh Chiu, Jian Yang, Shilpa Soni, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2009
Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administrationElias Gebru, Joong-Su Lee, Zhi-Qiang Chang, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2009
Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administrationMeng Li, Marilee A Andrew, Joanne Wang, et al.
Pageof 3,143